Clinical Trials Browser

Available × balstilimab × Tumor-Agnostic × Clear all

NCT05572970 2025-04-30

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Neoplasms